Singapore markets closed
  • Straits Times Index

    2,537.39
    +8.98 (+0.36%)
     
  • Nikkei

    23,516.59
    +42.32 (+0.18%)
     
  • Hang Seng

    24,918.78
    +132.65 (+0.54%)
     
  • FTSE 100

    5,860.28
    +74.63 (+1.29%)
     
  • BTC-USD

    12,949.76
    +53.17 (+0.41%)
     
  • CMC Crypto 200

    260.05
    -1.40 (-0.54%)
     
  • S&P 500

    3,465.39
    +11.90 (+0.34%)
     
  • Dow

    28,335.57
    -28.09 (-0.10%)
     
  • Nasdaq

    11,548.28
    +42.28 (+0.37%)
     
  • Gold

    1,903.40
    -1.20 (-0.06%)
     
  • Crude Oil

    39.78
    -0.86 (-2.12%)
     
  • 10-Yr Bond

    0.8410
    -0.0070 (-0.83%)
     
  • FTSE Bursa Malaysia

    1,494.64
    -4.16 (-0.28%)
     
  • Jakarta Composite Index

    5,112.19
    +20.37 (+0.40%)
     
  • PSE Index

    6,484.06
    +139.43 (+2.20%)
     

United States Fibromyalgia Market and Competitive Landscape 2020 - ResearchAndMarkets.com

·2-min read

The "US Fibromyalgia Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering.

The latest research US Fibromyalgia Market and Competitive Landscape Highlights - 2020, provides comprehensive insights into Fibromyalgia pipeline products, Fibromyalgia epidemiology, Fibromyalgia market valuations and forecast, Fibromyalgia drugs sales and competitive landscape in the US.

The research is classified into seven sections - Fibromyalgia treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.

Research Scope:

  • Fibromyalgia pipeline: Find out the products in clinical trials for the treatment of Fibromyalgia by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products

  • Fibromyalgia epidemiology: Find out the number of patients diagnosed (prevalence) with Fibromyalgia in the US

  • Fibromyalgia drugs: Identify key products marketed and prescribed for Fibromyalgia in the US, including trade name, molecule name, and company

  • Fibromyalgia drugs sales: Find out the sales revenues of Fibromyalgia drugs in the US

  • Fibromyalgia market valuations: Find out the market size for Fibromyalgia drugs in 2019 in the US. Find out how the market advanced from 2016 and forecast to 2025

  • Fibromyalgia drugs market share: Find out the market shares for key Fibromyalgia drugs in the US

Benefits of this Research:

  • Support monitoring and reporting national Fibromyalgia market analysis and sales trends

  • Track competitor drugs sales and market share in the US Fibromyalgia market

  • Track competitive developments in Fibromyalgia market and present key issues and learnings

  • Synthesize insights for Fibromyalgia market and products to drive business performance

  • Answer key business questions about the Fibromyalgia market

  • Evaluate commercial market opportunity assessment, positioning, and segmentation for Fibromyalgia products

  • Supports decision making in R&D to long term marketing strategies

Key Topics Covered:

1) Fibromyalgia Treatments

2) Fibromyalgia Pipeline

3) US Fibromyalgia Epidemiology

4) Marketed Drugs for Fibromyalgia in US

5) US Fibromyalgia Market Size and Forecast

6) US Fibromyalgia Products Sales and Forecast

7) US Fibromyalgia Market Competitive Landscape

8) Methodology

List of Tables

1. Fibromyalgia Phase 3 Clinical Trials, 2020

2. Fibromyalgia Phase 2 Clinical Trials, 2020

3. Fibromyalgia Phase 1 Clinical Trials, 2020

4. Fibromyalgia Epidemiology, US, 2016 - 2025

5. Marketed Drugs for Fibromyalgia, US, 2019

6. Fibromyalgia Market Size and Forecast ($), US, 2016 - 2025

7. Fibromyalgia Product Sales ($), US, 2016 - 2025

List of Figures

1. Fibromyalgia Epidemiology, US, 2016 - 2025

2. Fibromyalgia Market Size and Forecast ($), US, 2016 - 2025

3. Fibromyalgia Products Market Share (%), US, 2019

For more information about this report visit https://www.researchandmarkets.com/r/86sv4f

View source version on businesswire.com: https://www.businesswire.com/news/home/20200918005421/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900